RAPT Therapeutics RAPT 深 沪
已收盘 03-03 16:00:00 美东时间
58.02
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 58.02
- 总市值 16.80亿
- 52周最高 58.02
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 5.6656
- 委 比 0.00%
- 总股本 2896.06万
- 历史最高 409.68
- 量 比 0
- 振 幅 0.00%
- 历史最低 5.6656
- 每 手 1
- 风险率 16.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GSK Buys RAPT Therapeutics to Bolster Long-Acting Food Allergy Pipeline
GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has completed its $2....
03-03 23:02
GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play
GSK will acquire 35Pharma for $950 million, adding HS235, a new drug candidate targeting pulmonary hypertension affecting millions worldwide.
02-25 20:22
葛兰素史克(GSK.US)9.5亿美元收购35 Pharma，发力心血管药物赛道
葛兰素史克(GSK.US)已同意收购 35Pharma Inc.，这是一家拥有早期高血压药物资产的生物技术公司。此举标志着这家英国制药巨头正向心血管药物领域扩张...
02-25 16:45
UPDATE 2-GSK to buy 35Pharma for $950 million in CEO Miel's second major deal
UPDATE 2-GSK to buy 35Pharma for $950 million in CEO Miel's second major deal Acquisition boosts drugmaker's pipeline of respiratory medicines 35Pharma's drug has shown promise in mouse studies for obesity-related heart condition GSK shares have risen nearly 21% so far this year Rewrites paragraphs
02-25 15:27
GSK wins approval of Exdensur in Europe for severe asthma
The European Commission has approved GSK's (GSK) Exdensur (depemokimab) for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps. Approval was based on the results fro...
02-17 22:07
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
02-12 09:02
GSK’s Arexvy RSV vaccine accepted for regulatory review in China for seniors
GlaxoSmithKline (GSK) said on Tuesday that China’s Center for Drug Evaluation has accepted its regulatory application for Arexvy (RSV [recombinant, adjuvanted] vaccine) for review. The vaccine is inte...
02-10 21:02
GSK shares uptick for seven consecutive sessions
GSK (GSK) shares clocked seven straight sessions of gains, as the stock rose 1.9% at $60.29 on Friday. The multinational healthcare giant gained 16.8% in the preceding six sessions. The stock has surg...
02-07 04:39
GSK wins EU nod to expand Nucala for COPD
GSK (GSK) on Friday announced that the European Commission has approved its Nucala asthma therapy for patients with chronic obstructive pulmonary disease (COPD), expanding its label into five disease ...
02-07 00:35
葛兰素史克预计2026年销售额增长放缓 新任首席执行官米尔斯准备改变路线
葛兰素史克GSK.L周三在新任首席执行官卢克-米尔斯（Luke Miels）发表的首份展望报告中表示，预计2026年的销售额增长将比上年 有所放缓，因为 该公司...
02-04 18:14
